SM
Insider
Stephen F. Mahoney
President and CEOStephen F. Mahoney (President and CEO) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in Viridian Therapeutics, Inc. (VRDN). Across 1 priced purchase filing, the average 21-session return was -1.1% from execution and +2.3% from disclosure (delay-adjusted; derived). The largest single filing was $499K of VRDN (21,400 sh × $23.33, as filed), executed Sep 27 2024.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-1.1%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+2.3%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
3d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
–
no filings in the window
Last traded
Sep 27 2024
Filed Sep 30 2024
Median ADV $49.3M across their filed names
Open performance→Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
VRDNRecent filings
VRDNPURCHASE
Viridian Therapeutics, Inc.
View filing →
$499K21,400 sh × $23.33
Exec Sep 27 2024
Filed Sep 30 2024 · 5:30 PM ET